Page last updated: 2024-09-04

canertinib and interleukin-8

canertinib has been researched along with interleukin-8 in 1 studies

Compound Research Comparison

Studies (canertinib)	Trials (canertinib)	Recent Studies (post-2010) (canertinib)	Studies (interleukin-8)	Trials (interleukin-8)	Recent Studies (post-2010) (interleukin-8)
124	9	65	23,523	1,167	9,990

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Christensen, JG; Elliott, WL; Fry, DW; Klohs, WD; Leopold, WR; Vincent, PW	1

Other Studies

1 other study(ies) available for canertinib and interleukin-8

Article	Year
Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor. Molecular cancer therapeutics, 2005, Volume: 4, Issue:6 Topics: Administration, Oral; Animals; Biomarkers, Tumor; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Mice; Morpholines; Oncogene Proteins v-erbB; Protein Kinase Inhibitors; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays	2005

Article

Year

Plasma vascular endothelial growth factor and interleukin-8 as biomarkers of antitumor efficacy of a prototypical erbB family tyrosine kinase inhibitor.

Molecular cancer therapeutics, 2005, Volume: 4, Issue:6

Topics: Administration, Oral; Animals; Biomarkers, Tumor; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Humans; Interleukin-8; Mice; Morpholines; Oncogene Proteins v-erbB; Protein Kinase Inhibitors; RNA, Messenger; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2005